際際滷shows by User: edwrdbrgr / http://www.slideshare.net/images/logo.gif 際際滷shows by User: edwrdbrgr / Wed, 17 Jun 2015 14:12:24 GMT 際際滷Share feed for 際際滷shows by User: edwrdbrgr Berger - Drug Development with CDx 2015 - Final /slideshow/berger-drug-development-with-cdx-2015-final/49508981 76960158-46ba-484e-978f-93fdf945abfd-150617141224-lva1-app6892
]]>
]]> Wed, 17 Jun 2015 14:12:24 GMT /slideshow/berger-drug-development-with-cdx-2015-final/49508981 edwrdbrgr@slideshare.net(edwrdbrgr) Berger - Drug Development with CDx 2015 - Final edwrdbrgr <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/76960158-46ba-484e-978f-93fdf945abfd-150617141224-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Berger - Drug Development with CDx 2015 - Final from Edward Berger
]]> 513 3 https://cdn.slidesharecdn.com/ss_thumbnails/76960158-46ba-484e-978f-93fdf945abfd-150617141224-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Reimbursement Basics For Life Science Entrepreneurs /slideshow/reimbursement-basics-for-life-science-entrepreneurs/7628427 reimbursementbasicsforlifescienceentrepreneurs-13027940680811-phpapp01
What life science entrepreneurs really need to know about reimbursement]]>
What life science entrepreneurs really need to know about reimbursement]]> Thu, 14 Apr 2011 10:15:17 GMT /slideshow/reimbursement-basics-for-life-science-entrepreneurs/7628427 edwrdbrgr@slideshare.net(edwrdbrgr) Reimbursement Basics For Life Science Entrepreneurs edwrdbrgr What life science entrepreneurs really need to know about reimbursement <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/reimbursementbasicsforlifescienceentrepreneurs-13027940680811-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> What life science entrepreneurs really need to know about reimbursement
Reimbursement Basics For Life Science Entrepreneurs from Edward Berger
]]> 636 2 https://cdn.slidesharecdn.com/ss_thumbnails/reimbursementbasicsforlifescienceentrepreneurs-13027940680811-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Fda Cms Pro Industry Initiatives /slideshow/fda-cms-pro-industry-initiatives/7628392 fdacmsproindustryinitiatives-13027939011087-phpapp02
Are FDA/CMS &quot;pro-industry&quot; initiatives beneficial or harmful to emerging technologies?]]>
Are FDA/CMS &quot;pro-industry&quot; initiatives beneficial or harmful to emerging technologies?]]> Thu, 14 Apr 2011 10:12:51 GMT /slideshow/fda-cms-pro-industry-initiatives/7628392 edwrdbrgr@slideshare.net(edwrdbrgr) Fda Cms Pro Industry Initiatives edwrdbrgr Are FDA/CMS &quot;pro-industry&quot; initiatives beneficial or harmful to emerging technologies? <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/fdacmsproindustryinitiatives-13027939011087-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Are FDA/CMS &amp;quot;pro-industry&amp;quot; initiatives beneficial or harmful to emerging technologies?
Fda Cms Pro Industry Initiatives from Edward Berger
]]> 257 2 https://cdn.slidesharecdn.com/ss_thumbnails/fdacmsproindustryinitiatives-13027939011087-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Comparative Effectiveness Research:: Threat or Opportunity /slideshow/comparative-effectiveness-research-threat-or-opportunity-5271533/5271533 ebergercerwebinar9222010-128527410728-phpapp02
analysis of how comparative effectiveness research initiatives can change the life sciences competitive landscape]]>
analysis of how comparative effectiveness research initiatives can change the life sciences competitive landscape]]> Thu, 23 Sep 2010 15:37:52 GMT /slideshow/comparative-effectiveness-research-threat-or-opportunity-5271533/5271533 edwrdbrgr@slideshare.net(edwrdbrgr) Comparative Effectiveness Research:: Threat or Opportunity edwrdbrgr analysis of how comparative effectiveness research initiatives can change the life sciences competitive landscape <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ebergercerwebinar9222010-128527410728-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> analysis of how comparative effectiveness research initiatives can change the life sciences competitive landscape
Comparative Effectiveness Research:: Threat or Opportunity from Edward Berger
]]> 307 4 https://cdn.slidesharecdn.com/ss_thumbnails/ebergercerwebinar9222010-128527410728-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Reimbursement Strategy for Companion Diagnostics /slideshow/reimbursement-strategy-for-companion-diagnostics/3007586 ebergercompaniondiagnosticsslideshare12810-12646219416032-phpapp01
Summary of reimbursement issues and related business strategy concerns for commercialization of companion diagnostics]]>
Summary of reimbursement issues and related business strategy concerns for commercialization of companion diagnostics]]> Wed, 27 Jan 2010 13:54:28 GMT /slideshow/reimbursement-strategy-for-companion-diagnostics/3007586 edwrdbrgr@slideshare.net(edwrdbrgr) Reimbursement Strategy for Companion Diagnostics edwrdbrgr Summary of reimbursement issues and related business strategy concerns for commercialization of companion diagnostics <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ebergercompaniondiagnosticsslideshare12810-12646219416032-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Summary of reimbursement issues and related business strategy concerns for commercialization of companion diagnostics
Reimbursement Strategy for Companion Diagnostics from Edward Berger
]]> 2270 4 https://cdn.slidesharecdn.com/ss_thumbnails/ebergercompaniondiagnosticsslideshare12810-12646219416032-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-edwrdbrgr-48x48.jpg?cb=1522887183 Ed Berger has more than 25 years of experience working in senior management or as a consultant with medical device, biotechnology and health services companies, dealing with reimbursement issues and other problems at the intersection of U.S. and international health care policy, corporate strategy development, and strategically sensitive corporate communications with government, investors and the media. In 2005, Ed founded Larchmont Strategic Advisors to help life sciences companies create and implement integrated strategies to address the obstacles and opportunities they face in their efforts to secure public and private insurer coverage and optimal reimbursement for new or evolving tec... www.larchmontstrategic.com https://cdn.slidesharecdn.com/ss_thumbnails/76960158-46ba-484e-978f-93fdf945abfd-150617141224-lva1-app6892-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/berger-drug-development-with-cdx-2015-final/49508981 Berger - Drug Developm... https://cdn.slidesharecdn.com/ss_thumbnails/reimbursementbasicsforlifescienceentrepreneurs-13027940680811-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/reimbursement-basics-for-life-science-entrepreneurs/7628427 Reimbursement Basics F... https://cdn.slidesharecdn.com/ss_thumbnails/fdacmsproindustryinitiatives-13027939011087-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/fda-cms-pro-industry-initiatives/7628392 Fda Cms Pro Industry I...